NasdaqGS - Nasdaq Real Time Price
USD
Alkermes plc (ALKS)
42.71
+2.77
(+6.94%)
As of 3:24:51 PM EDT. Market Open.
Trade ALKS on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreLoading chart for ALKS
- Previous Close
39.94 - Open
40.00 - Bid 36.61 x 100
- Ask 48.74 x 100
- Day's Range
39.64 - 42.83 - 52 Week Range
25.17 - 42.83 - Volume
2,585,748 - Avg. Volume
2,336,264 - Market Cap (intraday)
7.119B - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
47.46 - EPS (TTM)
0.90 - Earnings Date (est.) Jul 28, 2026
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
45.44
Recent News
View More
Performance Overview
Trailing total returns as of 5/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
ALKS
52.64%
S&P 500 (^GSPC)
10.77%
1-Year Return
ALKS
41.19%
S&P 500 (^GSPC)
28.25%
3-Year Return
ALKS
45.67%
S&P 500 (^GSPC)
80.30%
5-Year Return
ALKS
88.40%
S&P 500 (^GSPC)
80.36%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
As of 5/28/2026
-
Market Cap
6.66B
-
Enterprise Value
7.73B
-
Trailing P/E
44.38
-
Forward P/E
105.26
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
4.30
-
Price/Book (mrq)
3.80
-
Enterprise Value/Revenue
4.95
-
Enterprise Value/EBITDA
27.96
Financial Highlights
Profitability and Income Statement
-
Profit Margin
9.77%
-
Return on Assets (ttm)
4.72%
-
Return on Equity (ttm)
9.36%
-
Revenue (ttm)
1.56B
-
Net Income Avi to Common (ttm)
152.72M
-
Diluted EPS (ttm)
0.90
Balance Sheet and Cash Flow
-
Total Cash (mrq)
511.86M
-
Total Debt/Equity (mrq)
90.30%
-
Levered Free Cash Flow (ttm)
140.55M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Mkt Cap
undefined
-
Industry
-
551.04
-1.97%
Mkt Cap
23.39B
Industry
Drug Manufacturers—Specialty & Generic
14.02
-1.41%
Mkt Cap
1.559B
Industry
Drug Manufacturers—Specialty & Generic
158.93
+1.62%
Mkt Cap
15.98B
Industry
Drug Manufacturers—Specialty & Generic
23.47
-0.89%
Mkt Cap
923.496M
Industry
Drug Manufacturers—Specialty & Generic
33.28
-0.27%
Mkt Cap
1.079B
Industry
Drug Manufacturers—Specialty & Generic
3.5401
-1.66%
Mkt Cap
582.748M
Industry
Drug Manufacturers—Specialty & Generic
48.47
-4.67%
Mkt Cap
3.729B
Industry
Drug Manufacturers—Specialty & Generic
23.43
-0.04%
Mkt Cap
151.409M
Industry
Drug Manufacturers—Specialty & Generic
8.88
-2.47%
Mkt Cap
2.256B
Industry
Drug Manufacturers—Specialty & Generic
Company Insights
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Learn more
Dividend Score
The distribution of earnings a company pays back to its shareholders based off the company’s profits. Usually paid out on a quarterly basis in the form of cash or additional stocks.
Hiring Score
A company’s hiring trends in key indicators can indicate how well the company is doing in terms of growing the company and where they are currently prioritizing.
Insider Sentiment Score
Vicker’s Insider Sentiment provides insights into trades made by insiders. This can be used to gain valuable insights and as a reflection of the prospect of the company based on insider trading.
